BioSpace News Archive

X4 Pharmaceuticals, Inc. announced the appointment of Françoise de Craecker to the company’s Board of Directors and the recent hiring of Karolyn Park to the newly created role of Vice President, U.S. Commercial, significantly strengthening the company’s depth and breadth of commercial leadership experience.

VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that it has enrolled the first patient in its Phase 1b/2a clinical trial evaluating FMX114 for the treatment of mild-to-moderate atopic dermatitis (AD).

Dr. Reddy’s Laboratories Ltd. announced the final approval of its Abbreviated New Drug Application for Lenalidomide Capsules, in 2.5 mg and 20 mg strengths, and tentative approval for 5 mg, 10 mg, 15 mg, and 25 mg strengths, a therapeutic equivalent generic version of REVLIMID® Capsules, from the U.S. Food and Drug Administration.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global Lewy Body Dementia treatment market is projected to surpass a valuation of US$ 3,500.5 Mn between 2018 and 2028, according to newly released data by Fact.MR.

Biotechnology Instruments Market growth is on the back of the increasing adoption of point-of-care diagnostic devices.

Growing concerns pertaining to the spread and frequency of COVID-19 variants across the globe is anticipated to boost the need for extensive screening and surveillance techniques in the upcoming years.

Hematopathology Is defined as the study of diseases that affect the blood cells in the body and thereby the clinical laboratories that carry out hematopathology services are termed as hematopathology clinical laboratories.

The Holter monitor market is anticipated to experience significant growth opportunities in the upcoming years.